Test directory: HPV High Risk PCR 16/18 Genotype

Ordering Code 7707
Test Name HPV High Risk PCR 16/18 Genotype
Alias Human Papillomavirus (HPV), High Risk with 16 and 18
Genotype by PCR, SurePath
HPV High Risk
HPV HR SurePath
Optimum Volume 3 mL
Handling Instructions Specimen source required.
Transport Requirements Oahu: Refrigerated
Airline: Refrigerated
Specimen Stability Ambient: 1 Month
Refrigerated: 6 Months
Frozen: Not Stable
Rejection Criteria Bloody or dark brown specimens, Specimens collected in other media
Avail. Stat NO
Analytic Time 10 Days
Methodology Qualitative Polymerase Chain Reaction
Reference Lab  ARUP Laboratories

Reference range(s)

The reference ranges listed below are valid on this date of June 1, 2025.
Component Age Male Norm Male Critical Low Male Critical High Female Norm Female Critical High Female Critical Low Units Add'l info
HPV Source ALL See report.
HPV Genotype 18 by PCR ALL See report.
HPV Genotype 16 by PCR ALL See report.
HPV, Other High Risk by PCR ALL

This test...
This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances
Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types, the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21

See report.
Note1

Note1:


This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances
Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types, the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21

See report..